Nexeon MedSystems Inc. Corporate Profile
Nexeon Medsystems, Inc. is a global medical device company focused on providing innovative neurostimulation products that improve the quality of life of patients suffering from debilitating neurological disease. Nexeon has developed and commercialized a neurostimulation system that can be utilized to treat a variety of neurological diseases.
Recent News
- Nexeon MedSystems Receives $830,000 grant from the National Institute of Neurological Disorders and Stroke
- Nexeon MedSystems Announces Second Quarter 2018 Financial Results
- Nexeon Receives “NXNN” Ticker Symbol from FINRA and Raises $1.165M
- Nexeon MedSystems Announces First Quarter 2018 Financial Results
- Nexeon MedSystems Appoints Wes Dittmer, CPA to Board of Directors
Corporate Overview
Email Alert Preferences
Sign up to get real-time information about all Company and Company-related activity.
Frequently Asked Questions
Nexeon MedSystems Inc. was incorporated in the State of Nevada on December 7, 2015.
Paritz & Company P.A.
Upon Approval of SEC and FINRA, the Company will trade on the OTC Markets QB Exchange
Action Stock Transfer Corporation
2469 E. Fort Union Blvd., Suite 214
Salt Lake City, UT 84121
Telephone: (801) 274-1088
Fax: (801) 274-1099
Email: mailto:[email protected]
The Company's SEC filings can be found through the SEC's website www.sec.gov
For investor inquiries, contact us at [email protected]
Following SEC and FINRA Approval
December 31
No. Nexeon does not pay dividends at this time.
For questions regarding changes to your existing stock certificate, contact us at [email protected]
No. Nexeon does not offer a direct stock purchase program.
Nexeon has not yet determined when or where it will hold its annual meetings. Upon finalized plans, the information will be posted on the website and emailed directly to shareholders.